NewsRx

Search our medical news database

Infectious Disease Therapy

Therapeutic drug monitoring of vancomycin improves efficacy

Published in TB and Outbreaks Week, July 29th, 2003

Therapeutic drug monitoring (TDM) improves the efficacy of vancomycin (VCM) treatment.

In a study from Japan, the utility of VCM TDM was "retrospectively investigated in 184 patients with methicillin-resistant Staphylococcus aureus (MRSA) infection."

"The incidence of nephrotoxicity was compared between the patients who received TDM practice (TDM group, n = 73) and did not (non-TDM group, n = 111)," according to T. Iwamoto and colleagues at Mie University. "Creatinine clearance (CLcr) values decreased significantly after the VCM therapy in the non-TDM group (p < 0.05)."

"The patients with MRSA bacteremia or pneumonia...

Want to see the full article?

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now


Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of TB and Outbreaks Week


NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook